language-icon Old Web
English
Sign In
Acemap > Field > Ubrogepant

Ubrogepant

Ubrogepant is an experimental drug for the treatment of migraine. It is a small-molecule calcitonin gene-related peptide receptor antagonist. Ubrogepant is an experimental drug for the treatment of migraine. It is a small-molecule calcitonin gene-related peptide receptor antagonist.

[ "Triptans", "Migraine treatment", "Calcitonin gene-related peptide", "Monoclonal antibody", "Calcitonin" ]
Parent Topic
Child Topic
    No Parent Topic
logo
  • CCF Conference Analysis
  • Map Galaxy
  • What's New
© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.